» Articles » PMID: 7685785

Pituitary Glycoprotein Hormones in Chronic Renal Failure: Evidence for an Uncontrolled Alpha-subunit Release

Overview
Publisher Springer
Specialty Endocrinology
Date 1993 Mar 1
PMID 7685785
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic renal failure affects the secretion of pituitary glycoprotein hormones by mechanism(s) that are still unknown. In this study, we evaluated serum concentrations of TSH, free thyroid hormones (FT4, FT3), LH, FSH, testosterone (T), and alpha-subunit (alpha-SU) in 25 uremic patients (19 males and 6 females), both in basal conditions and after stimulatory and inhibitory tests. Basal TSH levels were in the normal range, while FT4 and FT3 were significantly lower than in controls. Basal LH and FSH levels were clearly elevated. The LH levels measured by RIA were significantly higher than those measured by a "two-site" IRMA (48.9 +/- 16.5 vs 18.0 +/- 8.6 U/L) due to alpha-SU cross-reactivity in RIA. FSH bioactivity was normal in all patients. Serum T was normal in all but 3 males, without any correlation with LH and FSH levels. Serum alpha-SU concentrations were significantly elevated (5.5 +/- 3.0 vs 0.4 +/- 0.2 microgram/L). Of 17 patients, the TSH response to TRH was normal in 9 and impaired in 8, whereas alpha-SU response was normal in 5 and impaired in 12. In 8 male patients, TRH plus GnRH caused a normal LH and FSH response in 4 patients, while the increase of alpha-SU was normal in only one patient and significantly lower than expected in subjects with comparable basal alpha-SU levels in the remaining 7. In 2 patients, the combined suppression test with T undecanoate and T3 completely blocked TSH secretion and reduced both LH and FSH release by 30%, while serum alpha-SU levels did not change.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Cross-section of thyroidology and nephrology: Literature review and key points for clinicians.

Chehade J, Belal H J Clin Transl Endocrinol. 2024; 37:100359.

PMID: 39109356 PMC: 11301390. DOI: 10.1016/j.jcte.2024.100359.


The Prevalence of Thyroid Abnormalities in Patients With Chronic Kidney Disease: A Cross-Sectional Study at a Tertiary Care Hospital.

Raj R, Kumar V, Bhushan D, Biswas R, Ojha V Cureus. 2023; 15(8):e43065.

PMID: 37680414 PMC: 10481636. DOI: 10.7759/cureus.43065.


The Interplay Between Thyroid Dysfunction and Kidney Disease.

Narasaki Y, Sohn P, Rhee C Semin Nephrol. 2021; 41(2):133-143.

PMID: 34140092 PMC: 8221115. DOI: 10.1016/j.semnephrol.2021.03.008.


Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxins.

Santos G, Pantoja C, Costa E Silva A, Rodrigues M, Ribeiro R, Simeoni L Nucl Recept. 2005; 3(1):1.

PMID: 15807894 PMC: 1087878. DOI: 10.1186/1478-1336-3-1.

References
1.
Cowden E, Ratcliffe W, Ratcliffe J, Dobbie J, Kennedy A . Hyperprolactinaemia in renal disease. Clin Endocrinol (Oxf). 1978; 9(3):241-8. DOI: 10.1111/j.1365-2265.1978.tb02206.x. View

2.
Lim V, Henriquez C, Seo H, Refetoff S, Martino E . Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism. J Clin Invest. 1980; 66(5):946-54. PMC: 371530. DOI: 10.1172/JCI109963. View

3.
Handelsman D, Ralec V, Tiller D, HORVATH J, Turtle J . Testicular function after renal transplantation. Clin Endocrinol (Oxf). 1981; 14(5):527-38. DOI: 10.1111/j.1365-2265.1981.tb00642.x. View

4.
Blackman M, Weintraub B, Kourides I, Solano J, Santner T, ROSEN S . Discordant elevation of the common alpha-subunit of the glycoprotein hormones compared to beta-subunits in serum of uremic patients. J Clin Endocrinol Metab. 1981; 53(1):39-48. DOI: 10.1210/jcem-53-1-39. View

5.
Wheatley T, Clark P, Clark J, Holder R, Raggatt P, Evans D . Abnormalities of thyrotrophin (TSH) evening rise and pulsatile release in haemodialysis patients: evidence for hypothalamic-pituitary changes in chronic renal failure. Clin Endocrinol (Oxf). 1989; 31(1):39-50. DOI: 10.1111/j.1365-2265.1989.tb00452.x. View